Prediction of atrial fibrillation according to levels of serum markers of inflammation during arterial hypertension
- Authors: Vasilets LM1, Agafonov AV1, Khlynova OV1, Ratanova EA1, Grigoriadi NE2, Krivaya AA1, Trenogina KV1
-
Affiliations:
- Perm State Medical Academy, Perm, Russia
- Perm Regional Clinical Hospital, Perm, Russia
- Issue: Vol 93, No 4 (2012)
- Pages: 642-646
- Section: Theoretical and clinical medicine
- URL: https://bakhtiniada.ru/kazanmedj/article/view/1561
- DOI: https://doi.org/10.17816/KMJ1561
- ID: 1561
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
L M Vasilets
Perm State Medical Academy, Perm, Russia
A V Agafonov
Perm State Medical Academy, Perm, Russia
O V Khlynova
Perm State Medical Academy, Perm, Russia
E A Ratanova
Perm State Medical Academy, Perm, Russia
Email: lena.ratanova@mail.ru
N E Grigoriadi
Perm Regional Clinical Hospital, Perm, Russia
A A Krivaya
Perm State Medical Academy, Perm, Russia
K V Trenogina
Perm State Medical Academy, Perm, Russia
References
- Маркин С.С., Ольбинская Л.И., Игнатенко С.Б. Фактор некроза опухолей в плазме крови и морфофункциональные параметры сердца у больных с хронической сердечной недостаточностью, осложнившей течение ишемической болезни сердца, динамика под влиянием лечения // Терап. арх. - 2003. - №2. - С. 54-58.
- Насонов Е.Л., Панюкова Е.В., Александрова Е.Н. С-реактивный белок - маркёр воспаления при атеросклерозе (новые данные) // Кардиология. - 2002. - №7. - С. 53-62.
- Термосесов С.А., Вотчал Ф.Б., Костылёва О.В. и др. Немедикаментозные методы лечения фибрилляции предсердий // Сердеч. недост. - 2001. - Т. 2, №5. - С. 231-234.
- Bradham W.S., Bozkurt B., Gunasinghe H. et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective // Cardiovasc. Res. - 2002. - Vol. 53. - P. 822-830.
- Chung M.K., Martin D.O., Sprecher D. et al. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation // Circulation. - 2001. - Vol. 104. - P. 2886.
- Deng Hai, Xue Yu-mei, Zhan Xian-zhang et al. Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation // Chin. Med. J. - 2011. - Vol. 124, N 13. - P. 1976-1982.
- Dernellis J., Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation // Amer. Heart J. - 2005. - Vol. 150. - P. 12-14.
- Go A.S., Hylek E.M., Phillips K.A. et al. Prevalence of diagnosed atrial fibrillation in adults // JAMA. - 2001. - Vol. 285. - Р. 2370-2375.
- Koening W., Sund M., Frohlich M. et al. C-reactive protein a sensitive marker of inflammation, predict future risk of coronary heart disease in initially healthy middle-aged men // Circulation. - 1999. - Vol. 99. - P. 237-242.
- Naoyuki S., Naokazu H., Takashi H. et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? // Jpn. Heart J. - 2004. - Vol. 45, N 3. - P. 441-445.
- Peason T.A., Mensah G.A., Wayne A.R. et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the centers for disease control and prevention and American Heart Association // Circulation. - 2003. - Vol. 107. - P. 499-511.
- Rodney H. Falk atrial fibrillation // New Engl. J. Med. - 2001. - Vol. 344, N 14. - Р. 1067-1078.
- Sun M., Chen M., Dawood F. et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state // Circulation. - 2007. - Vol. 115, N 11. - P. 1398-1407.
- Yeh E.T.H., Anderson H.V., Pasceri V., Willerson J.T. C-reactive protein. Linking inflammation to cardiovascular complications // Circulation. - 2001. - Vol. 104. - P. 974.
Supplementary files
